Skip to Content

Making Personalized Medicine Real

Today, Roche announced they have acquired Bina Technologies.  Bina Technologies provides a next- generation genomic analysis platform which provides insight to genomic data.  The acquisition demonstrates Roche’s commitment to personalized medicine  combining bio-pharma with diagnostics to drive towards personalized medicine therapies.  The acquisition demonstrates Life Science companies need to invest in new powerful technologies to support their strategies.

Be the first to leave a comment
You must be Logged on to comment or reply to a post.